Atlas Private Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Atlas Private Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,329	Closed	-$208K	–	166
2023 Q4	$208K	Sell	2,329 -742	-24%	-$55.1K	0.04%	153
2023 Q3	$224K	Sell	3,071 -350	-10%	-$28K	0.04%	166
2023 Q2	$285K	Buy	+3,421	New	+$286K	0.06%	153
2022 Q2	–	Sell	-3,137	Closed	-$282K	–	147
2022 Q1	$282K	Sell	3,137 -51	-2%	-$4.71K	0.13%	113
2021 Q4	$357K	Hold	3,188	–	–	0.17%	105
2021 Q3	$401K	Hold	3,188	–	–	0.21%	96
2021 Q2	$432K	Sell	3,188 -158	-5%	-$20.8K	0.23%	82
2021 Q1	$454K	Buy	3,346 +163	+5%	+$24.4K	0.25%	79
2020 Q4	$448K	Buy	3,183 +179	+6%	+$22.9K	0.3%	73
2020 Q3	$335K	Buy	3,004 +40	+1%	+$4.48K	0.28%	75
2020 Q2	$332K	Buy	+2,964	New	+$292K	0.3%	76

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Atlas Private Wealth Advisors's XBI Position: Q1 2024 in Review

Atlas Private Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 2,329 shares — an estimated $208K sold.

Atlas Private Wealth Advisors first reported a position in XBI in Q2 2020 and held it in 11 quarters. The position peaked at $454K in Q1 2021. 782 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Atlas Private Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Atlas Private Wealth Advisors sold 2,329 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $208K.
Atlas Private Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 11 quarters.
Atlas Private Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $454K in Q1 2021.
782 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Atlas Private Wealth Advisors's 13F filing for Q1 2024, filed 6 May 2024.